2022
DOI: 10.17504/protocols.io.36wgq7d83vk5/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Proteogenomics Reference Database Protocol v1

Abstract: Therapeutic approaches to treat melanoma include small molecule drugs that target activating protein mutations in pro-growth signaling pathways like the MAPK pathway. While beneficial to the approximately 50% of patients with activatingBRAFV600mutation, mono- and combination therapy with MAPK inhibitors is ultimately associated with acquired resistance. To better characterize the mechanisms of MAPK inhibitor resistance in melanoma, we utilize patient-derived xenografts and apply proteogenomic approaches levera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Specifically, the ligand binding energies are facet dependent, and can vary depending on whether a CdSe NC, for example, is wurtzite or zinc blende. 118,119 Computational studies investigating the crystal structures of various NC compositions can provide insight into trap sites and how to mitigate them on a case-by-case basis. 120 For CdSe NC systems, surface trap sites have been theorized to result from a lone pair on Se or an empty orbital on Cd.…”
Section: Size Dependencementioning
confidence: 99%
“…Specifically, the ligand binding energies are facet dependent, and can vary depending on whether a CdSe NC, for example, is wurtzite or zinc blende. 118,119 Computational studies investigating the crystal structures of various NC compositions can provide insight into trap sites and how to mitigate them on a case-by-case basis. 120 For CdSe NC systems, surface trap sites have been theorized to result from a lone pair on Se or an empty orbital on Cd.…”
Section: Size Dependencementioning
confidence: 99%
“…Compounds 1 and 2 were prepared in accordance with the literature. [ 40 ] Weigh out the compound 2 (0.205 g, 1.0 mmol) and ethyl mercaptan (0.248 g, 2.0 mmol) in 20 ml of dichloromethane. The catalyst ether boron trifluoride (0.10 ml, 0.79 mol) was slowly added dropwise to the above system at 0 °C, and the reaction was stirred overnight at the above temperature.…”
Section: Experiments Proceduresmentioning
confidence: 99%